- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
SolRayo CEO Kevin Leonard, Joint Development Partner of Enable IPC, to Discuss Ultracapacitor Technology
Enable IPC Corporation (OTCBB: EIPC) today announced that its joint development partner, SolRayo, will participate in a poster session at the Nanotech 2007 Conference in Santa Clara, California on Wednesday, May 23rd at 2:00 p.m. The subject of the poster will be the ultracapacitor technology, which is the focus of the two companies' joint development effort.
Kevin Leonard, CEO of SolRayo and co-inventor of the technology (with Dr. Marc Anderson of the University of Wisconsin), will conduct the poster session. The presentation is titled "Synthesis and Characterization of Electrochemical Capacitors Using Nanoporous SiO2". Mr. Leonard will describe the technology's unique use of SiO2 (Silicon Dioxide, or Silica), which is considered an insulator but behaves like a conductor in this case.
The conference will take place at the Santa Clara Convention Center from May 20th - 24th. More information can be found at http://www.nsti.org/Nanotech2007 .
Enable IPC previously announced that the company will also host a poster session at the conference on Tuesday, May 22 at 4:00 pm. During this session a representative from the company will discuss Enable IPC's unique method of creating nanowires -- free standing poles, approximately 1/1000th the diameter of a human hair. They are a key part of Enable IPC's patent pending microbattery technology. Microbatteries are used in some "smart" cards, RFID tags, small medical devices and a number of other applications. The microbattery market has been independently estimated to grow to over $3 billion in the next five years.
To be added to Enable IPC's corporate update list for shareholders and interested investors, please send an e-mail to .
About Enable IPC Corporation
Enable IPC Corporation is developing power devices using advances in thin films and nanotechnology. Our products include microbatteries for very low power applications (utilizing nanowires as small as 1/1000th the diameter of a human hair) and ultracapacitors for a wide range of power applications (utilizing nanoparticles on carbon). These complementary products will be ideal for use in a variety of applications. The microbattery is targeted for use in healthcare products, RFID tags, smart cards and many other applications while the ultracapacitor is to be used in consumer electronics.
This release contains forward-looking statements, such as "believes," "expected," "targeted" and similar terminology, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties which could cause actual results that the Company achieves to differ materially from any of the forward-looking statements. Such risks and uncertainties, include, but are not limited to, the following: the timely development and market acceptance of products and technologies, the ability to secure additional sources of financing, the difficulties in forecasting results from development efforts, difficulties in accurately estimating market growth, the impact of changing economic conditions, business conditions in the microbattery industry and others identified in our Annual Report on Form 10-KSB, as amended, and other Securities and Exchange Commission filings. The company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information, please click here
Enable IPC Corporation
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage
X-rays and electrons join forces to map catalytic reactions in real-time: New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions June 29th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015